SchumacherGABeebeGWKiblerRF, et al. Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci1965; 122: 552–568.
2.
McDonaldWICompstonDAEdanG, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50: 121–127.
3.
PolmanCHReingoldSCEdanG, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol2005; 58: 840–846.
4.
PolmanCHReingoldSCBanwellB, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria. Ann Neurol2011; 69(2): 292–302.
5.
ThompsonABanwellBBarkoffF, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald Criteria. Lancet Neurol2018; 17(2): 162–173.
6.
FilippiMRoccaMACiccarelliO, et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol2016; 15(3): 292–303.
7.
TintoreMRoviraABrievaL, et al. Isolated demyelinating syndromes: Comparison of CSF oligoclonal bands and different MRI criteria to predict conversion to CDMS. Mult Scler2001; 7(6): 359–363.
8.
TintoreMRoviraARioJ, et al. Defining high, medium, and low impact prognostic factors for developing multiple sclerosis. Brain2015; 138(7): 1863–1874.
9.
PoserCMPatyDWScheinbergL, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protcols. Ann Neurol1983; 13: 227–231.
10.
BrownleeWJSwantonJKMiszkielKA, et al. Should the symptomatic region be included in dissemination in space in MRI criteria for MS?Neurology2016; 87(7): 680–683.
11.
TintoreMOtero-RomeroSRioJ, et al. Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis. Neurology2016; 87(13): 1368–1374.
12.
FilippiMRoccaMACalabreseM, et al. Intracortical lesions: Relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology2010; 75(22): 1988–9414.
13.
LublinFDReingoldSCCohenJA, et al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology2014; 83(3): 278–286.
14.
WingerchukDMBanwellBBennettJL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology2015; 85(2): 177–189.
